Judge Delays Construction of Arizona Observatory

The endangered red squirrel gets a 120-day reprieve, while Congress reconsiders its support of Mount Graham complex TUCSON -- Two years ago, astronomers and their supporters climbed up Capitol Hill and won approval for a $200 million observatory on an Arizona mountaintop. Many people thought that was the end of a four-year struggle between astronomers and people who opposed observatory development (The Scientist, Nov. 28, 1988, page 5; and Jan. 22, 1990, page 4). But last month, a federal cour

Written byMark Holman Turner
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share


The endangered red squirrel gets a 120-day reprieve, while Congress reconsiders its support of Mount Graham complex
TUCSON -- Two years ago, astronomers and their supporters climbed up Capitol Hill and won approval for a $200 million observatory on an Arizona mountaintop. Many people thought that was the end of a four-year struggle between astronomers and people who opposed observatory development (The Scientist, Nov. 28, 1988, page 5; and Jan. 22, 1990, page 4). But last month, a federal court temporarily halted construction on the Mount Graham site. And within days of that decision by United States District Judge Alfredo C. Marquez, Rep. Morris K. Udall (D-Ariz.) requested that the House subcommittee on national parks and public lands hold an oversight hearing about the matter. In short, the fate of the mountain is far from settled.

At the core of this latest flare-up is a U.S. Fish and Wildlife Service ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies